Table: Delta-Fly Pharma - 6-MTH parent results

Delta-Fly Pharma

11/11/2021 06:00

Nov 11 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2021        Sep 30, 2020       Mar 31, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            100 mln             100 mln           100 mln     
                 (+0.0 pct)                            (-66.7 pct)   
  Operating     loss 554 mln        loss 463 mln        loss 1.30    
  Recurring     loss 555 mln        loss 463 mln        loss 1.30    
  Net           loss 557 mln        loss 464 mln        loss 1.30    
  EPS          loss 102.97 yen     loss 103.22 yen   loss 239.87 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T